Genitourinary Infections Flashcards
What kinds of organisms are common in bacterial vaginosis?
Anaerobes:
Gardnerella vaginalis, Mycoplasma hominis, Mobiluncus species, Bacteroides species (other than Bacteroides fragilis)
What kinds of organisms are common in VVC?
Candida species
The most common pathogen in VVC is…
Candida albicans
Risk factors of VVC include:
Impaired immune status Broad-spectrum abx Inhibition of normal bacterial flora 30% test + after 2-3 week course of TETRACYCLINE Post treatment for trichomoniasis or BV CORTICOSTEROID medications Pregnancy Diabetes Changes in glycogen
Which GU infection has thick and curdy (“cottage cheese-like” discharge?
VVC
Which GU infection has normal vaginal pH, a negative “Whiff” test, and the presence of pseudohyphae on wet mounts?
VVC
A recurrent VVC is considered ____ or more episodes of symptomatic VVC in
3 or more episodes in <1 year
Women with these conditions are considered to have complicated VVCs:
Diabetes, Immunocompromising conditions (HIV), underlying immunodeficiency, or immunosuppressive therapy (corticosteroids)
Uncomplicated VVC treatment
OTC intravaginal agents:
Clotrimazole 1% or 2% cream, Miconazole 2% or 4$ cream [5g intravaginally daily ranging from 3-14 days], miconazole 100 mg or 200 mg vaginal suppository for 3-7 days
Oral agent:
Fluconazole 150 mg orally in a single dose
What is the treatment for severe vaginitis (complicated)?
Fluconazole 100, 150, or 200 mg PO q___h for ___ doses
OR
Topical antifungal therapy daily for _____ days
q72h for 3 doses [3 doses total, 9 days to complete]
OR
topical therapy daily for 7-14 days
What is the treatment for recurrent VVC (complicated) - maybe no longer albicans but a different species of candida?
Induction:
___ days of oral or topical therapy
Maintenance:
Fluconazole 100, 150, 200 mg ______ for _____ months
Induction: 7-14 days of oral or topical therapy
Maintenance: weekly for 6 months
Treatment for treatment failure/non-albicans candida vaginitis:
C. glabrata - intravaginal ____ acid _____ mg daily for ____ days
C. krusei - intravaginal ____ acid ____ mg daily for ____ days OR non-fluconazole (oral or topical) azole for _____ days
C. glabrata: boric acid 600 mg daily for 21 days
C. krusei: boric acid 600 mg daily for 21 days or non-fluconazole (oral or topical) azole for 7-14 days
New treatment approved for adult and post-menarchal pediatric females with VVC
Brexafemme (ibrexafungerp)
Oral VVC drug that is contraindicated during pregnany and a strong CYP3A4 inducer
Brexafemme (ibrexafungerp)
Which GU infection has an elevated vaginal pH (~5), a positive “Whiff” test, and thin, white discharge?
Bacterial vaginosis